ReviewFrontiers in plant science2026
Spray-induced gene silencing for plant disease control: mechanistic basis and deployment-oriented design.
Review in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Spray-Induced Gene Silencing (SIGS) of Dual-Target Genes (Journal of fungi (Basel, Switzerland) · 2026Article
- Calcium Alginate-Based Hydrogel-Encapsulated Nutrients and Nucleic Acid Delivery for Ameliorating Saline-Alkali Stress in Plants.Gels (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spray-induced gene silencing (SIGS) is a transgene-free, biodegradable RNA-based approach for crop protection in which exogenously applied double-stranded RNA (dsRNA) is taken up and processed by plants or susceptible pathogens to drive the sequence-specific silencing of essential or virulence-associated genes. This review synthesizes advancements in transitioning SIGS from proof-of-concept to field-relevant deployment. Here, we frame SIGS as a two-compartment process: (i) dsRNA deposition on foliage, access to cuticular/apoplastic microenvironments, processing into small interfering RNAs (siRNAs), amplification, and systemic movement within plants; and (ii) pathogen acquisition of dsRNA/siRNAs at infection interfaces, followed by RNA interference (RNAi) execution, with outcomes strongly conditioned by pathogen RNA-uptake competence and, in some systems, cross-kingdom RNA trafficking. Because performance is often constrained by exposure rather than sequence potency, we evaluated the key determinants of delivery and persistence and compared carrier strategies that extend stability and bioavailability, including layered double hydroxide clays, vesicle-inspired lipid systems, polymer complexes, and carbon-based nanomaterials. We then consolidated the mechanism-informed design rules for target selection, within-transcript positioning, and dsRNA architecture, along with specificity, non-target risk, and durability/escape management. Finally, we defined the current scope boundaries, including the limited applicability to bacterial phytopathogens lacking canonical eukaryotic RNAi. We outline deployment-oriented priorities for achieving reliable SIGS performance under realistic agricultural conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.